Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A cystic adenocarcinoma characterized by the presence of relatively uniform neoplastic cells which produce pancreatic enzymes and are arranged in acinar patterns. Signs and symptoms include abdominal pain, weight loss, nausea, and diarrhea. It usually has an aggressive clinical course.
Biomarker and diagnostic research for pancreatic acinar cell cystadenocarcinoma has been reported in the published literature.
No clinical trials have been registered for pancreatic acinar cell cystadenocarcinoma.
4 publications have been identified in PubMed for pancreatic acinar cell cystadenocarcinoma. Research spans Case Report / Case Series (75%) and Diagnostic / Biomarker (25%).
Hirano M (2025). [PMID: 40008371](https://pubmed.ncbi.nlm.nih.gov/40008371/). *Surgical case reports*. [Case Report / Case Series]
Trieu J (2025). [PMID: 40232932](https://pubmed.ncbi.nlm.nih.gov/40232932/). *Cancer cytopathology*. [Diagnostic / Biomarker]
Koo TH (2025). [PMID: 40771911](https://pubmed.ncbi.nlm.nih.gov/40771911/). *Case reports in gastroenterology*. [Case Report / Case Series]
Ines FMGS (2024). [PMID: 39537224](https://pubmed.ncbi.nlm.nih.gov/39537224/). *Annals of clinical and laboratory science*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 6:09 PM UTC
AI-curated news mentioning pancreatic acinar cell cystadenocarcinoma
Updated May 1, 2026
A systematic review highlights single-center experiences with pancreatic acinar cell cystadenoma, providing insights into its clinical management. This research contributes to the understanding of this rare pancreatic tumor.
A recent autopsy case study reveals multiple liver metastases originating from minute pancreatic acinar cell carcinoma, initially misdiagnosed as primary hepatic acinar cell carcinoma. This finding underscores the complexity of diagnosing pancreatic tumors and their metastatic behavior.